A Phase 3, Randomized, Double-Blind, Two-Phase, Multicenter Study toEvaluate the Efficacy and Safety of Vonoprazan 20 mg Compared to Lansoprazole 30 mg for Healing in Patients with Erosive Esophagitis and to Evaluate the Efficacy and Safety of Vonop
Administered By
Awarded By
Contributors
- Leiman, David Asher Principal Investigator
Start/End
- May 1, 2020 - April 30, 2023